Interleukin-6 (IL-6): A Possible Neuromodulator Induced by Neuronal Activity

IL-6 and its receptor(s) are found in the CNS in health and disease. Cellular sources are glial cells and neurons. Glial production of IL-6 has intensively been studied, but comparatively little is known about the induction of IL-6 in neurons. Emerging evidence suggests that IL-6 possesses neurotrophic properties. Recent data show that neuronal IL-6 expression is induced by excitatory amino acids or membrane depolarization. This implicates that IL-6 is produced not only under pathological conditions but may play a critical role as a physiological neuromodulator that is induced by neuronal activity and regulates brain functions. In the following article, the authors review the current data on IL-6 expression in neurons, with special reference to the induction of IL-6 by neuronal activity. They discuss its direct and indirect effects as a neuromodulator and speculate about the possible function of IL-6 as a physiological regulatory molecule and as a neuroprotective agent in brain pathology.

[1]  M. Schwaninger,et al.  The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice , 2003, Behavioural Brain Research.

[2]  H. Monyer,et al.  Regulation of Body Temperature and Neuroprotection by Endogenous Interleukin-6 in Cerebral Ischemia , 2003, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[3]  Kinji Inoue,et al.  Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways , 2001, Neuroscience Letters.

[4]  F. Fauchereau,et al.  Neuronal Targeting of Cardiotrophin-1 by Coupling with Tetanus Toxin C Fragment , 2001, Molecular and Cellular Neuroscience.

[5]  T. Pollmächer,et al.  Cytokine-associated emotional and cognitive disturbances in humans. , 2001, Archives of general psychiatry.

[6]  R. Oppenheim,et al.  Cardiotrophin-1, a Muscle-Derived Cytokine, Is Required for the Survival of Subpopulations of Developing Motoneurons , 2001, The Journal of Neuroscience.

[7]  J. Hidalgo,et al.  Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures , 2001, Neuroscience.

[8]  Simon A. Jones,et al.  The soluble interleukin 6 receptor: mechanisms of production and implications in disease , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[9]  H. Boddeke,et al.  Interleukin-6 Enhances Expression of Adenosine A1 Receptor mRNA and Signaling in Cultured Rat Cortical Astrocytes and Brain Slices , 2001, Neuropsychopharmacology.

[10]  M. Schwaninger,et al.  Induction of Interleukin-6 by Depolarization of Neurons , 2000, The Journal of Neuroscience.

[11]  A. Miettinen,et al.  Interleukin-6 and Interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic–clonic seizures , 2000, Epilepsy Research.

[12]  L. Acarín,et al.  Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain , 2000, The European journal of neuroscience.

[13]  Kortaro Tanaka,et al.  Expression of interleukin‐6 is suppressed by inhibition of voltage‐sensitive Na+/Ca2+ channels after cerebral ischemia , 2000, Neuroreport.

[14]  R. Dantzer,et al.  Role of IL-6 in cytokine-induced sickness behavior a study with IL-6 deficient mice , 2000, Physiology & Behavior.

[15]  G. D’Arcangelo,et al.  The Inhibitory Effects of Interleukin‐6 on Synaptic Plasticity in the Rat Hippocampus Are Associated with an Inhibition of Mitogen‐Activated Protein Kinase ERK , 2000, Journal of neurochemistry.

[16]  S. Garattini,et al.  Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus , 2000, The European journal of neuroscience.

[17]  J. Kurek.  AM424: History Of A Novel Drug Candidate , 2000, Clinical and experimental pharmacology & physiology.

[18]  E. Mackenzie,et al.  Ischemia-Induced Interleukin-6 as a Potential Endogenous Neuroprotective Cytokine against NMDA Receptor-Mediated Excitoxicity in the Brain , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  G. D’Arcangelo,et al.  Interleukin‐6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex , 2000, The European journal of neuroscience.

[20]  Kortaro Tanaka,et al.  Immunohistochemical Detection of Leukemia Inhibitory Factor After Focal Cerebral Ischemia in Rats , 2000, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[21]  E. Senba,et al.  Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. , 2000, Journal of neurotrauma.

[22]  J. Bockaert,et al.  “Inflammatory” Cytokines , 2000, Journal of neurochemistry.

[23]  Jing Han,et al.  Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro , 2000, The European journal of neuroscience.

[24]  A. Davies,et al.  Cytokine-Induced Nuclear Factor Kappa B Activation Promotes the Survival of Developing Neurons , 2000, The Journal of cell biology.

[25]  D. Corbett,et al.  Temperature Modulation (Hypothermic and Hyperthermic Conditions) and Its Influence on Histological and Behavioral Outcomes Following Cerebral Ischemia , 2000, Brain pathology.

[26]  B. Barres,et al.  The relationship between neuronal survival and regeneration. , 2000, Annual review of neuroscience.

[27]  E. Nagata,et al.  Temporal Profile and Cellular Localization of Interleukin-6 Protein after Focal Cerebral Ischemia in Rats , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  S. Rogers,et al.  Inflammatory Cytokines IL-1α, IL-1β, IL-6, and TNF-α Impart Neuroprotection to an Excitotoxin Through Distinct Pathways , 1999, The Journal of Immunology.

[29]  S. Wiese,et al.  Developmental Requirement of gp130 Signaling in Neuronal Survival and Astrocyte Differentiation , 1999, The Journal of Neuroscience.

[30]  P. Wahle,et al.  Sensory Impairments and Delayed Regeneration of Sensory Axons in Interleukin-6-Deficient Mice , 1999, The Journal of Neuroscience.

[31]  P. Richardson,et al.  Nature of the Retrograde Signal from Injured Nerves that Induces Interleukin-6 mRNA in Neurons , 1999, The Journal of Neuroscience.

[32]  S. Rose-John,et al.  Role of interleukin‐6 and soluble IL‐6 receptor in region‐specific induction of astrocytic differentiation and neurotrophin expression , 1999 .

[33]  Markus Schwaninger,et al.  NF-κB is activated and promotes cell death in focal cerebral ischemia , 1999, Nature Medicine.

[34]  V. Hans,et al.  Experimental Axonal Injury Triggers Interleukin-6 mRNA, Protein Synthesis and Release into Cerebrospinal Fluid , 1999, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[35]  S. Rogers,et al.  Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. , 1999, Journal of immunology.

[36]  L C Katz,et al.  Neurotrophins and synaptic plasticity. , 1999, Annual review of neuroscience.

[37]  J. G. Netzeband,et al.  Chronic Interleukin-6 Alters NMDA Receptor-Mediated Membrane Responses and Enhances Neurotoxicity in Developing CNS Neurons , 1998, The Journal of Neuroscience.

[38]  A. Armario,et al.  IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6 , 1998, Journal of Neuroimmunology.

[39]  P. Heinrich,et al.  Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. , 1998, The Biochemical journal.

[40]  K. Frei,et al.  IL‐6‐deficient mice resist myelin oligodendrocyte glycoprotein‐induced autoimmune encephalomyelitis , 1998, European journal of immunology.

[41]  M. Iglesias,et al.  Calmodulin Is Involved in Membrane Depolarization-Mediated Survival of Motoneurons by Phosphatidylinositol-3 Kinase- and MAPK-Independent Pathways , 1998, The Journal of Neuroscience.

[42]  A. Davies,et al.  Cytokines promote the survival of mouse cranial sensory neurones at different developmental stages , 1998, The European journal of neuroscience.

[43]  B. Leonard,et al.  Depression, stress and immunological activation: the role of cytokines in depressive disorders. , 1998, Life sciences.

[44]  H. Przuntek,et al.  Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. , 1998, Acta neurologica Scandinavica.

[45]  D. Parkes,et al.  Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures. , 1997, Endocrinology.

[46]  U. Otten,et al.  Interleukin-6 (IL-6)—A molecule with both beneficial and destructive potentials , 1997, Progress in Neurobiology.

[47]  S. Opal,et al.  Characterization of Early Cytokine Responses and an Interleukin (IL)-6–dependent Pathway of Endogenous Glucocorticoid Induction during Murine Cytomegalovirus Infection , 1997, The Journal of experimental medicine.

[48]  J. Schölmerich,et al.  Neuronal Regulation of Interleukin 6 Secretion in Murine Spleen: Adrenergic and Opioidergic Control , 1997, Journal of neurochemistry.

[49]  H. Kiyama,et al.  Characteristic Localization of gpl30 (the Signal‐transducing Receptor Component Used in Common for IL‐6/IL‐11/CNTF/LIF/OSM) in the Rat Brain , 1996, The European journal of neuroscience.

[50]  M. Sakanaka,et al.  Interleukin-6 prevents ischemia-induced learning disability and neuronal and synaptic loss in gerbils , 1996, Neuroscience Letters.

[51]  V. Poli,et al.  Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1 beta: a study on IL-6-deficient mice , 1996, The Journal of experimental medicine.

[52]  J. Heroux,et al.  Interleukin-6 mRNA expression by cortical neurons in culture: Evidence for neuronal sources of interleukin-6 production in the brain , 1995, Journal of Neuroimmunology.

[53]  F. Brett,et al.  Evolution of Neuropathologic Abnormalities Associated with Blood-Brain Barrier Breakdown in Transgenic Mice Expressing lnterleukin-6 in Astrocytes , 1995, Journal of neuropathology and experimental neurology.

[54]  ChristianBlomstrand,et al.  Early Intrathecal Production of Interleukin-6 Predicts the Size of Brain Lesion in Stroke , 1995 .

[55]  U. Otten,et al.  Identification of interleukin-6 (IL-6)-expressing neurons in the cerebellum and hippocampus of normal adult rats , 1994, Neuroscience Letters.

[56]  F. Holsboer,et al.  Gene expression and function of interleukin I, interleukin 6 and tumor necrosis factor in the brain , 1994, Progress in Neurobiology.

[57]  M E Greenberg,et al.  Requirement for BDNF in activity-dependent survival of cortical neurons. , 1994, Science.

[58]  L. Mucke,et al.  Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  S. Akira,et al.  Interleukin-6 in biology and medicine. , 1993, Advances in immunology.

[60]  J. Bauer,et al.  Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[61]  E. Johnson,et al.  Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells. , 1989, Proceedings of the National Academy of Sciences of the United States of America.